For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Genome Therapeutics Corporation

USPTO Granted Patents = 19

Forward Citations = 895

Loading Chart...

Loading Chart...

32 inventors (with patents filed for the assignee):

David E Bush (8 out of 68 patents)

Lynn Doucette-Stamm (4 out of 59 patents)

Randall D Little (4 out of 13 patents)

4. Gary L Breton (4 out of 5 patents)

5. Jen-i Mao (3 out of 6 patents)

6. Jason Samuel Simon (2 out of 15 patents)

7. Tim Keith (2 out of 9 patents)

8. Paul Van Eerdewegh (2 out of 9 patents)

9. Kristina Allen (2 out of 12 patents)

10. Sunil D Pandit (2 out of 9 patents)

11. Craig Deloughery (2 out of 3 patents)

12. Keith G Weinstock (2 out of 3 patents)

13. John P Carulli (2 out of 4 patents)

14. Robert R Recker (2 out of 9 patents)

15. Mark L Johnson (2 out of 6 patents)

19 patents: Sort by Forward Citations

1. 7285400 - High bone mass gene of 11q13.3 (2007-10-23),

2. 7041814 - [object Object] (2006-05-09),

3. 6800744 - Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics (2004-10-05),

4. 6780609 - High bone mass gene of 1.1q13.3 (2004-08-24),

5. 6747137 - Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics (2004-06-08),

6. 6737519 - Human genes relating to respiratory diseases and obesity (2004-05-18),

7. 6699703 - Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics (2004-03-02),

8. 6683165 - Human gene relating to respiratory diseases and obesity (2004-01-27),

9. 6673910 - Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics (2004-01-06),

10. 6610836 - Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics (2003-08-26),

11. 6605709 - Nucleic acid and amino acid sequences relating to Proteus mirabilis for diagnostics and therapeutics (2003-08-12),

12. 6583275 - Nucleic acid sequences and expression system relating to Enterococcus faecium for diagnostics and therapeutics (2003-06-24),

13. 6583266 - Nucleic acid and amino acid sequences relating to mycobacterium tuberculosis and leprae for diagnostics and therapeutics (2003-06-24),

14. 6562958 - Nucleic acid and amino acid sequences relating to Acinetobacter baumannii for diagnostics and therapeutics (2003-05-13),

15. 6551795 - Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics (2003-04-22),

Genome Therapeutics Corporation is a biotechnology company specialized in drug discovery and development. With a focus on genomics and genetics, they aim to identify novel therapeutic targets and develop innovative treatments for various diseases. Through extensive research and collaborations, Genome Therapeutics has built a strong pipeline of potential drug candidates. Their mission is to improve the lives of patients by translating scientific discoveries into effective therapies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

19 Patents

#64 in Waltham, MA

#1,008 in Massachusetts

#16,627 in US

#31,713 in the World

Waltham, MA, United States of America

Genome Therapeutics Corporation

Forward Citations = 895

32 inventors:

David E Bush (8 out of 68 patents)

Lynn Doucette-Stamm (4 out of 59 patents)

Randall D Little (4 out of 13 patents)

4. Gary L Breton (4 out of 5 patents)

5. Jen-i Mao (3 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…